<DOC>
	<DOCNO>NCT00658905</DOCNO>
	<brief_summary>The purpose study evaluate efficacy preterm infant follow treatment BSSL administer infant formula .</brief_summary>
	<brief_title>Efficacy Safety Bile Salt Stimulated Lipase ( BSSL ) Replacement Therapy Infant Formula Preterm Infants</brief_title>
	<detailed_description>In double-blind crossover study , patient randomize receive infant formula include BSSL infant formula without BSSL first 7 day . After wash-out period 2 day patient `` crossover '' treatment regimen receive additional 7 day treatment . The primary efficacy measurement make collect stool last three day treatment period .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<criteria>Preterm infant less equal 32 week gestational age appropriate gestational age enterally feed infant formula</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Preterm infant</keyword>
	<keyword>Replacement therapy</keyword>
	<keyword>Infant formula</keyword>
	<keyword>BSSL</keyword>
	<keyword>BSSL present fresh mother 's milk infant formula .</keyword>
</DOC>